Clinical Trial Update: Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether dexmedetomidine can prevent ischemia-reperfusion–induced glycocalyx degradation and early allograft dysfunction i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Assiut University | Conditions: Liver Transplant; Complications | Phase 4 | Status: ACTIVE_NOT_RECRUITING